Operating Lease, Right-of-Use Asset of Protagonist Therapeutics, Inc from 01 Jan 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Protagonist Therapeutics, Inc quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 30 Sep 2025.
  • Protagonist Therapeutics, Inc Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $8,174,000, a 17% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Protagonist Therapeutics, Inc Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $8,174,000 -$1,661,000 -17% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $8,589,000 -$1,663,000 -16% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $9,000,000 +$8,613,000 +2226% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $9,417,000 +$8,463,000 +887% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $9,835,000 +$8,331,000 +554% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $10,252,000 +$8,215,000 +403% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $387,000 -$2,169,000 -85% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $954,000 -$2,107,000 -69% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 $1,504,000 -$2,045,000 -58% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $2,037,000 -$1,986,000 -49% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $2,556,000 -$1,929,000 -43% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $3,061,000 -$1,875,000 -38% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 $3,549,000 -$1,822,000 -34% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $4,023,000 -$326,000 -7.5% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $4,485,000 -$168,000 -3.6% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $4,936,000 -$14,000 -0.28% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 $5,371,000 +$136,000 +2.6% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $4,349,000 -$1,162,000 -21% 30 Jun 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 $4,653,000 -$1,127,000 -19% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $4,950,000 -$1,092,000 -18% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $5,235,000 -$1,060,000 -17% 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 $5,511,000 -$1,028,000 -16% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $5,780,000 -$999,000 -15% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $6,042,000 -$1,458,000 -19% 31 Dec 2019 10-K 10 Mar 2021 2020 FY
Q3 2019 $6,295,000 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $6,539,000 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $6,779,000 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 $7,500,000 01 Jan 2019 10-K 10 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.